Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: irritation (100), swelling (252), soreness (53), tenderness (24), redness (101)

Superficial thrombophlebitis - patient information

Description: Patient information factsheet Superficial thrombophlebitis We have written this factsheet to give you information on superficial thrombophlebitis. It incl
Url: /Media/UHS-website-2019/Patientinformation/Blooddisorders/Superficial-thrombophlebitis-2267-PIL.pdf

Lung stereotactic ablative body radiotherapy (SABR) - patient information

Description: This factsheet explains what lung stereotactic ablative body radiotherapy (SABR) is and what to expect during treatment.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Lung-stereotactic-ablative-body-radiotherapy-SABR-2091-PIL.pdf

Azathioprine for interstitial lung disease (ILD) - patient information

Description: This factsheet contains useful information about the medicine azathioprine.
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Azathioprine-for-interstitial-lung-disease-ILD-patient-information.pdf

Mycophenolate for interstitial lung disease (ILD) - patient information

Description: This factsheet contains useful information about the medicine mycophenolate mofetil (MMF).
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Mycophenolate-for-interstitial-lung-disease-ILD-patient-information.pdf

Press release: Doctors trial new vaccine to protect babies against life-threatening respiratory infections

Description: Doctors in Southampton are trialling a new vaccine that could prevent babies developing a virus which can cause life-threatening respiratory
Url: /AboutTheTrust/Newsandpublications/Latestnews/2019/October/Press-release-Doctors-trial-new-vaccine-to-protect-babies-against-life-threatening-respiratory-infections.aspx

Southampton researchers find arthritis drug could reduce dementia risk

Description: Researchers in Southampton have found drugs used to treat rheumatoid arthritis could halve the risk of developing dementia.
Url: /AboutTheTrust/Newsandpublications/Latestnews/2018/February-2018/Southampton-researchers-find-arthritis-drug-could-reduce-dementia-risk.aspx

James Ashton

Description: Auto Generated Title Congratulations to Dr James Ashton, who has been awarded a clinical research training fellowship by the child
Url: /ClinicalResearchinSouthampton/For-researchers/Education-and-training/Careerpathways/Inspirational-career-stories/James-Ashton.aspx

Cemiplimab

Description: Chemotherapy Protocol SKIN CANCER Cemiplimab (350mg) Regimen  Skin – Cemiplimab (350mg) Indication  Metastatic or locally advanced cutaneous squamous cell carcinoma in patients who ar
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Cemiplimab.pdf

Durvalumab_14day

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Durvalumab (14 day) Regimen • NSCLC - Durvalumab (14 day) Indication • Stage 3 NSCLC after radical chemoradiotherapy • WHO per
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Durvalumab-14day.pdf

Durvalumab(28day-1500mg)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Durvalumab (28 day – 1500mg) Regimen • NSCLC - Durvalumab (28 day – 1500mg) Indication • Durvalumab is indicated where; - the
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Durvalumab28day-1500mg.pdf

1 to 10 of 152

Previous 1 2 3 4 5 … Next